高级检索
当前位置: 首页 > 详情页

Development and initial validation of a traditional Chinese medicine symptom-specific outcome measure: a Zheng-related atopic dermatitis symptom questionnaire (ZRADSQ)

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ SSCI

机构: [1]The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. [2]Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada. [3]Beijing Aerospace General Hospital, Beijing, China. [4]The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Road, PO Box 510120, Guangzhou, China.
出处:
ISSN:

关键词: Atopic dermatitis Development Questionnaire Traditional Chinese medicine Validation Symptom

摘要:
Background: Zheng represents pattern differentiation in Traditional Chinese Medicine (TCM), as the basic unit and a key concept in TCM therapeutic theory, is based on the physiology and pathology of TCM. None of the outcome measurements of atopic dermatitis (AD) are Zheng-specific. The effectiveness of TCM is likely to be underestimated without a Zheng-related symptom-specific instrument. The aim of this study was to develop an instrument for measuring the Zheng-related symptom-specific status of patients with AD. Methods: We followed standard methodology to develop the instrument, including item generation and selection, item reduction and presentation, and pretesting, and recruited 188 patients with AD involved in a six-center randomized-controlled trial (ChiCTR-TRC-08000156) to validate the questionnaire. We conducted construct validity, reliability, and responsiveness analysis. The standardized effect size (SES) and standardized response mean (SRM) were used to calculate the responsiveness of additional items and the total score for the rating items. Results: ZRADSQ has 15 items, with 12 rating items and 3 additional items. The 12 rating items fall within three domains: AD symptoms (n = 6 items); Heat (n = 4 items) and Mood (n = 2 items). Confirmatory factor analysis provided good support for a three-factor model (d.f. = 51, x(2)=97.11, RMSEA = 0.07, CFI = 0.96), and the Pearson's correlation coefficient between ZRADSQ and Severity Scoring of Atopic Dermatitis (SCORAD) was 0.40 (P < 0.001). The reliability was also good, with a Cronbach's alpha value for ZRADSQ of 0.84, a split-half coefficient of 0.75, and a test-retest reliability coefficient of 0.98. The standardized effect size and standardized response mean were close to or larger than 1, which indicated moderate to good responsiveness. Conclusions: The ZRADSQ demonstrates promising reliability, validity, and responsiveness. It can be used to determine whether Zheng-specific or symptom-specific treatments relieve the symptom that is most bothersome the patient.

基金:

基金编号: 2007BA120B048

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 3 区 医学
小类 | 3 区 卫生保健与服务
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务 2 区 卫生政策与服务
JCR分区:
出版当年[2011]版:
Q2 HEALTH POLICY & SERVICES Q2 HEALTH CARE SCIENCES & SERVICES
最新[2023]版:
Q1 HEALTH CARE SCIENCES & SERVICES Q1 HEALTH POLICY & SERVICES

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. [2]Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada.
通讯作者:
通讯机构: [1]The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. [4]The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Road, PO Box 510120, Guangzhou, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号